Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline
Authors:
- Zhi ZhouZZZhi Zhou
- Martijn L.T.M. MüllerMMMartijn L.T.M. Müller
- Prabesh KanelPKPrabesh Kanel
- Jason ChuaJCJason Chua
- Vikas KotagalVKVikas Kotagal
- Daniel I. KauferDKDaniel I. Kaufer
- Roger L. AlbinRARoger L. Albin
- Kirk A. FreyKFKirk A. Frey
- Nicolaas I. BohnenNBNicolaas I. Bohnen
- 28 January 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 94 (4) , e376-e383
Abstract
Objective To determine whether β-amyloidopathy correlates with apathy rating scores independently of mood changes and other neurodegenerative processes in Parkinson disease (PD). Methods In this cross-sectional study, patients with PD (n = 64, 48 male and 16 female, mean age 69.2 ± 6.7 years, Hoehn & Yahr stage 2.7 ± 0.5, Montreal Cognitive Assessment score 25.3 ± 3.0) underwent [11C]Pittsburgh compound B β-amyloid, [11C]dihydrotetrabenazine vesicular monoamine transporter type 2 (VMAT2), and [11C]methyl 4 piperidinyl propionate acetylcholinesterase brain PET imaging and clinical assessments, including the Marin Apathy Evaluation Scale, Clinician Version. Patients were recruited on the basis of having at least 1 risk factor for PD dementia, but they were excluded if they had dementia. Results Mean apathy rating score was 25.4 ± 6.4, reflecting predominantly subclinical apathy. Apathy rating scale scores correlated with amyloid binding, cognitive, depressive, and anxiety scores but not significantly with age, duration of disease, striatal VMAT2, or cholinergic binding. Multiple regression analysis model (p < 0.0001) showed significant regressor effects for global β-amyloid burden (p = 0.0038) with significant covariate effects for global cognitive z scores (p = 0.028) and for anxiety (p = 0.038) but not with depressive scores. Voxel-based analysis showed robust correlation between apathy rating scale scores and β-amyloid binding in bilateral nuclei accumbens, inferior frontal, and cingulate cortices (family-wise error rate–corrected p < 0.005). Conclusion Apathy is independently associated with β-amyloidopathy in patients with PD at risk of dementia. Regional brain findings are most robust for β-amyloidopathy in the nuclei accumbens, inferior frontal, and cingulate regions. Findings may provide an explanation for the often treatment-refractory nature of apathy in advancing PD despite optimized dopaminergic and antidepressant pharmacotherapy. ClinicalTrials.gov identifier: NCT01565473.Keywords
This publication has 48 references indexed in Scilit:
- Cerebral Amyloid Deposition and Serotoninergic Innervation in Parkinson DiseaseArchives of Neurology, 2012
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesMovement Disorders, 2012
- Highlighting the versatility of the tracerlab synthesis modules. Part 1: fully automated production of [18F]labelled radiopharmaceuticals using a Tracerlab FXFNJournal of Labelled Compounds and Radiopharmaceuticals, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Dissociating apathy and depression in Parkinson diseaseNeurology, 2006
- Changes in motor subtype and risk for incident dementia in Parkinson's diseaseMovement Disorders, 2006
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Kinetic Analysis of [11C]MP4A Using a High-Radioactivity Brain Region That Represents an Integrated Input Function for Measurement of Cerebral Acetylcholinesterase Activity without Arterial Blood SamplingJournal of Cerebral Blood Flow & Metabolism, 2001
- Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume EffectsJournal of Cerebral Blood Flow & Metabolism, 1992
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969